Search results
Gene therapy and employee benefits: from science fiction to medical reality
BenefitsPRO· 3 days agoAs of late May 2024, 14 gene therapies are FDA-approved for a range of conditions including sickle ...
Retired shipyard designer waits for lifeline
WAVY via Yahoo News· 2 days agoPORTSMOUTH, Va. (WAVY) — Over the years, Newport News Shipbuilding senior designer John Slade Jr. was on hand for the commissionings and the overhauls of...
Rep. Sheila Jackson Lee announces cancer diagnosis, will miss time for treatment
United Press International via Yahoo News· 3 days agoLongtime Rep. Sheila Jackson Lee, D-Texas, announced on Sunday that she is suffering from pancreatic...
Are We Closer to a Cure for Diabetes? - Slashdot
Slashdot· 4 days agoThe researchers' results were published earlier in May in Cell Discovery, and are now getting some serious scrutiny from the press. The Economic Times cites a University of ...
Greeley girl fights rare, life-threatening blood disorder with positive attitude, deep bonds with...
Greeley Tribune· 5 days agoAubrie Dawson experienced a roller coaster of health scares that put her in a lot of...
DARZALEX® (daratumumab)-based regimens significantly improve clinical outcomes in both transplant...
Valley City Times Record· 2 days agoThe rates of deep and sustained MRD negativity were associated with improved progression-free...
Advances in CAR T-Cell Therapy for Multiple Myeloma
MedPage Today· 6 days agoB-cell maturation antigen (BCMA)-directed CAR T-cell therapies are now established options for treating multiple myeloma after relapse, but efforts are...
Man, 91, makes history by being first in England to receive artificial cornea
Daily Express· 1 day agoAfter an initial failed surgery with a human cornea, Farley’s surgeon offered him the chance to skip...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 6 days agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting
Quadruplet Regimens Have Become Standard for Multiple Myeloma
MedPage Today· 6 days agoWhile triplet regimens were once standard for newly diagnosed multiple myeloma, more recent studies...
